Sickle cell therapy pioneered at CHOP a "real gamechanger"
The FDA recently approved the first gene therapies to treat patients with sickle cell disease, an inherited blood disorder. Children's Hospital of Philadelphia helped pioneer the treatment, which experts say is a "real gamechanger" for this disease, which mainly affects people of color.